Journal article
The effects of mefloquine treatment in pregnancy
F Nosten, M Vincenti, J Simpson, P Yei, undefined Kyaw Lay Thwai, A De Vries, T Chongsuphajaisiddhi, NJ White
Clinical Infectious Diseases | UNIV CHICAGO PRESS | Published : 1999
DOI: 10.1086/515183
Abstract
We investigated the relationship between mefloquine antimalarial treatment and the outcome of pregnancy in Karen women living in an area along the western border of Thailand where multidrug-resistant Plasmodium falciparum infections are common. Of 3,587 pregnancies investigated, 208 (5.8%) were exposed to mefloquine, 656 (18.3%) to quinine only, and 909 (25.3%) to other antimalarials, and 2,470 (68.9%) had no documented malaria. There were 61 stillbirths and 313 abortions. Women who received mefloquine treatment during but not before pregnancy had a significantly greater risk of stillbirth than did women treated with quinine alone (odds ratio [OR], 4.72; 95% confidence interval [CI], 1.7-12...
View full abstract